Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: A Study of Maribavir in Adults and Children With Post-transplant Cytomegalovirus (CMV) Infection in Argentina
This clinical trial update indicates that maribavir is being studied in adults and children with post-transplant cytomegalovirus infection i…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Anti-viral T-cell Therapy by Gamma Capture [Phase 1, Phase 2]
Phase 1/2 clinical trial update of an anti-viral T-cell therapy using Gamma Capture for viral infections, currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency [NA]
Clinical trial update on using cytomegalovirus-specific donor-derived T lymphocytes to treat recalcitrant cytomegalovirus infection in a pat…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
This clinical trial examines immunoglobulin-specific prophylaxis to prevent cytomegalovirus infections in immunocompromised children undergo…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients [Phase 2]
An open-label Phase 2 study evaluating oral letermovir for CMV prophylaxis in thoracic transplant recipients is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of low-dose interleukin-2 in patients with systemic lupus erythematosus and cytome…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of antiviral cellular therapy intended to enhance T-cell reconstitution around hemato…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients [Phase 4]
Phase 4 trial update indicating Letermovir is being studied for secondary prophylaxis of cytomegalovirus infection in solid organ transplant…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study
This clinical trial update discusses a liver transplant study on herpesvirus immunology in solid organ transplant recipients, currently acti…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: Comparison Diagnostic Tests for the Diagnosis of CYTOmegalovirus Organ Disease in Patients With intestinalBOweL Diseases
A clinical trial is comparing diagnostic tests for CMV organ disease in patients with inflammatory bowel disease to identify the most accura…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: ATG Individualized Dosing Model in URD-PBSCT. [Phase 2]
Phase 2 trial updating an individualized dosing model of antithymocyte globulin in unrelated donor peripheral blood stem cell transplantatio…
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Non Primary HCMV Infection: Natural History and Immune Response
This clinical trial update concerns non-primary cytomegalovirus infection, focusing on its natural history and immune response. The study is…
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: Expansion of Virus-Specific Lymphocytes for Cell Therapy [Phase 1]
Phase 1 study expanding virus-specific lymphocytes for cytomegalovirus infection and CMV viremia is currently recruiting. Sponsor: Hospital …
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis [Phase 1, Phase 2]
The document describes a Phase 1/2 clinical trial evaluating adoptive cord blood immunotherapy to prevent or treat reactivation/infection wi…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy [Phase 2]
A Phase 2 clinical trial evaluating adoptive cell immunotherapy as prophylaxis against cytomegalovirus infection is currently recruiting.
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Evaluation of CMV/EBV-CMI in Haploid HSCT
A study evaluating CMV/EBV-specific cellular immune responses in haploid hematopoietic stem cell transplantation is currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Cytomegalovirus Reactivation in ICU Patients Requiring Prolong Mechanical Ventilation
This clinical trial update reports a study on cytomegalovirus reactivation in ICU patients requiring prolonged mechanical ventilation, and t…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Multicenter Quantitative and Qualitative Study of the Determinants of Participation in a Cytomegalovirus Preventive Vaccine Study in France in Women Aged 18 to 40 Years Old.
Multicenter qualitative and quantitative study in France aims to identify determinants of participation in a cytomegalovirus preventive vacc…
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis
A cohort-study analysis evaluating the incidence and risk factors of CMV reactivation in patients receiving CAR-T cell therapy for relapse o…
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection [Phase 2]
A Phase 2a study of IV BCV for adenovirus infection is currently recruiting, with cytomegalovirus infection also listed among the conditions…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT
A clinical trial evaluating whether Letermovir prophylaxis enhances CMV-specific immune reconstitution after umbilical cord blood transplant…
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Viral Specific T-Lymphocytes to Treat Adenovirus or CMV [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Viral Specific T-Lymphocytes for Adenovirus infection and Cytomegalovirus infection; the study is curren…
-
CLINICAL_TRIALS research · 2017-07-06Clinical Trial Update: Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients
This clinical trial update investigates how the absence of CMV-specific CD8+ T cell responses in CMV-seropositive donors may affect CMV reac…
-
CLINICAL_TRIALS research · 2017-03-07Clinical Trial Update: Diaplacental Transfer of Anti-HCMV- and Anti-VZV-immunoglobulin G (IgG) -Antibodies at Premature and Mature Newborns
The trial investigates placental transfer of anti-CMV IgG and anti-VZV IgG antibodies to premature and full-term newborns. Current status of…
-
CLINICAL_TRIALS research · 2016-12-02Clinical Trial Update: The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population
The trial update discusses strategies to prevent cytomegalovirus infection in Chinese patients who have undergone renal transplant.